Peripheral blood mononuclear cells (PBMCs) from patients who have received an FDA-approved COVID-19 vaccine.
Loading...
Loading...
Loading...
Loading...
COVID-19 Vaccinated PBMCs
| Size | 10 million PBMCs |
| Estimated Lead Time | 1-2 business days |
| Species | Human, SARS-CoV-2 |
| Research Area | Infectious Disease, COVID-19 |
| Shipping Type | Dry ice (additional shipping fee) |
Your cart is empty.
COVID-19 Vaccinated PBMCs